Is there a role for TNFα antagonists in the treatment of SSc ?

Abstract

To obtain experiences and expert opinion on treatment of SSc patients with TNF-α 

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Distler2017IsTA, title={Is there a role for TNFα antagonists in the treatment of SSc ?}, author={J{\"o}rg H. W. Distler and Suzana Jordan and Paolo Air{\'o} and Juan Jos{\'e} Alegre-Sancho and Yannick Allanore and Alexandra Balbir Gurman and Roberto Caporali and Paolo Caramaschi and Patricia Esmeralda Carreira and Carlo Chizzolini and Maur{\'i}zio Cutolo and Mehmet Tuncay Duru{\"o}z and Dominique Farge-Bancel and Roger Hesselstrand and Florenzo Iannone and Filip De Keyser and Eugene Joseph Kucharz and David Launay and Olga Lukacova and Bianca Marasini and Duska Martinovi{\'c} and Jo{\~a}o Francisco Marques Neto and Mislav Radi{\'c} and Simona Rednic and Gabriela Riemekasten and Josef Rovensky and Matthias F. Seidel and Soner Şenel and Vanessa Khouri Smith and Cord H Sunderk{\"o}tter and Evelien Ton and Jacob M. van Laar and Marco Matucci-Cerinic and Ulf Mueller-Ladner and Oliver Distler}, year={2017} }